Surgery Partners Q2 2023 Earnings Report
Key Takeaways
Surgery Partners reported revenue of $667.6 million, representing an 8.5% increase year-over-year. Net income attributable to Surgery Partners was $18.9 million, and Adjusted EBITDA was $100.2 million, a 16.4% increase. The company raised its full-year Adjusted EBITDA guidance to greater than $435 million and reaffirmed its revenue guidance at greater than $2.75 billion.
Revenue increased by 8.5% to $667.6 million, inclusive of an $8 million cyber event headwind.
Same-facility revenues grew by 8.3%, or approximately 10% when adjusted for the cyber event.
Net income attributable to Surgery Partners was $18.9 million.
Adjusted EBITDA increased by 16.4% to $100.2 million, with margin improving over 100 basis points to 15.0%.
Surgery Partners
Surgery Partners
Surgery Partners Revenue by Segment
Forward Guidance
The Company raises projected 2023 Adjusted EBITDA to be greater than $435 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income